Jeremy M Levin Ovid Therapeutics Inc. (OVID) insider trading activity
Jeremy M Levin is CEO of Ovid Therapeutics Inc.. Currently has a direct ownership of 3.69 Million shares of OVID, which is worth approximately $4.83 Million. The most recent transaction as insider was on Dec 15, 2025, when has been sold 71,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
3.69M
1.96%
3M change
1.96%
12M change
Total Value Held
$4.83 Million
JEREMY M LEVIN Transaction History
JML
Jeremy M Levin
CEO
New York, NY